Market Research Logo

Global Antiviral Drugs Market 2017-2021

Global Antiviral Drugs Market 2017-2021

About Antiviral Drugs

Antiviral drugs are agents used to cure a viral infection by inhibiting the growth of viral pathogens. There are two types of antiviral agents which includes narrow-spectrum antiviral agents and broad-spectrum antiviral agents.

Technavio’s analysts forecast the global antiviral drugs market to grow at a CAGR of 9.48% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global antiviral drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of antiviral drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Antiviral Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Gilead Sciences
  • GlaxoSmithKline
Other prominent vendors
  • AbbVie
  • Johnson & Johnson
  • Merck
  • Novartis
Market driver
  • Stockpiling by public healthcare agencies
  • For a full, detailed list, view our report
Market challenge
  • Need for proper storage conditions of antiviral drugs
  • For a full, detailed list, view our report
Market trend
  • Technological advancements
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the Report
  • Research Methodology
  • Introduction
    • Key market highlights
    • Key vendor offerings
      • Table Few major products offered by the key vendors
  • Disease Overview
    • Viral disease
      • Table HIV treatment regimen approved by FDA
      • Table Hepatitis treatment regimen approved by FDA
      • Table Herpes treatment regimen approved by FDA
  • Market landscape
    • Market overview
      • Table Global antiviral drugs market snapshot
      • Table Key marketed products
      • Table Global antiviral drugs market 2016-2021 ($ billions)
      • Table Opportunity analysis of global antiviral drugs market
    • Five forces analysis
  • Pipeline analysis
    • Table Snapshot of pipeline molecules (2016)
    • Table Pipeline analysis
  • Market segmentation by therapies
    • Table Global antiviral drugs market segmentation by therapies
    • Global hepatitis therapeutics market
      • Table Acute hepatitis cases in US 2000-2014
      • Table Global hepatitis therapeutics market 2016-2021 ($ billions)
    • Global HIV/AIDS therapeutics market
      • Table Global HIV/AIDS therapeutics market 2016-2021 ($ billions)
    • Global herpes therapeutics market
      • Table Number of women patients with HSV 2 in US 2000-2014
      • Table Global herpes therapeutic market 2016-2021 ($ billions)
    • Global influenza therapeutics market
      • Table Global influenza therapeutics market 2016-2021 ($ billions)
  • Market segmentation by MOA
    • Table Global antiviral drugs market segmentation by MOA
    • Table Market share of different segments based on MOA 2016
    • Reverse transcriptase inhibitors
    • Protease inhibitors
    • Entry/Fusion inhibitors
    • Immune system modulators
  • Geographical segmentation
    • Table Global antiviral drugs market segmentation by geography 2016 and 2021
    • Table Global antiviral drugs market revenue by geography 2016-2021 ($ billions)
    • Antiviral drugs market in Americas
      • Table Market scenario in Americas
      • Table Antiviral drugs market in Americas 2016-2021 ($ billions)
    • Antiviral drugs market in EMEA
      • Table Market scenario in EMEA
      • Table Antiviral drugs market in EMEA 2016-2021 ($ billions)
    • Antiviral drugs market in APAC
      • Table Market scenario in APAC
      • Table Antiviral drugs market in APAC 2016-2021 ($ billions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Seasonal influenza vaccine: Total doses distributed in millions
    • Impact of drivers on key customer segments
      • Table Impact of drivers
    • Market challenges
    • Forcefield analysis of impact of drivers and challenges
      • Table Impact of challenges
  • Market trends
    • Technological advancements
    • Combination therapy
    • Mergers and acquisitions
    • Growing partnerships
  • Competitive Landscape
    • Competitive scenario
      • Table Competitive structure analysis of global antiviral drugs market 2016
      • Table Competitive analysis of global antiviral drugs market
  • Key vendor analysis
    • Bristol-Myers Squibb
      • Table Bristol-Myers Squibb: Geographical segmentation in terms of revenue in 2015
      • Table Bristol-Myers Squibb: Strength assessment
      • Table Bristol-Myers Squibb: Strategy assessment
      • Table Bristol-Myers Squibb: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffman-La Roche: Strength assessment
      • Table F. Hoffman-La Roche: Strategy assessment
      • Table F. Hoffman-La Roche: Opportunity assessment
    • Gilead Sciences
      • Table Gilead Sciences: Strength assessment
      • Table Gilead Sciences: Strategy assessment
      • Table Gilead Sciences: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report